Common Stock, Shares, Outstanding of NEKTAR THERAPEUTICS from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
NEKTAR THERAPEUTICS quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • NEKTAR THERAPEUTICS Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 20,378,832, a 65% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

NEKTAR THERAPEUTICS Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 20,378,832 +7,993,831 +65% 31 Dec 2025 10-K 13 Mar 2026 2025 FY
Q3 2025 19,652,513 -164,805,487 -89% 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 12,457,252 -171,603,748 -93% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 186,103,000 +2,479,000 +1.4% 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 12,385,001 -178,998,999 -94% 31 Dec 2024 10-K 13 Mar 2026 2025 FY
Q3 2024 184,458,000 -6,313,000 -3.3% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 184,061,000 -6,058,000 -3.2% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 183,624,000 -5,611,000 -3% 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q4 2023 191,384,000 +2,824,000 +1.5% 31 Dec 2023 10-K 14 Mar 2025 2024 FY
Q3 2023 190,771,000 +2,817,000 +1.5% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 190,119,000 +2,714,000 +1.4% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 189,235,000 +2,961,000 +1.6% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 188,560,000 +3,092,000 +1.7% 31 Dec 2022 10-K 05 Mar 2024 2023 FY
Q3 2022 187,954,000 +3,400,000 +1.8% 30 Sep 2022 10-Q 04 Nov 2022 2022 Q3
Q2 2022 187,405,000 +3,632,000 +2% 30 Jun 2022 10-Q 05 Aug 2022 2022 Q2
Q1 2022 186,274,000 +3,984,000 +2.2% 31 Mar 2022 10-Q 06 May 2022 2022 Q1
Q4 2021 185,468,000 +5,377,000 +3% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 184,554,000 +5,160,000 +2.9% 30 Sep 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 183,773,000 +4,963,000 +2.8% 30 Jun 2021 10-Q 06 Aug 2021 2021 Q2
Q1 2021 182,290,000 +4,427,000 +2.5% 31 Mar 2021 10-Q 07 May 2021 2021 Q1
Q4 2020 180,091,000 +3,586,000 +2% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 179,394,000 +3,608,000 +2.1% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 178,810,000 +3,844,000 +2.2% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 177,863,000 +3,635,000 +2.1% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 176,505,000 +2,975,000 +1.7% 31 Dec 2019 10-K 26 Feb 2021 2020 FY
Q3 2019 175,786,000 +2,729,000 +1.6% 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 174,966,000 +2,551,000 +1.5% 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 174,228,000 +11,849,000 +7.3% 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 173,530,000 +14,006,000 +8.8% 31 Dec 2018 10-K 28 Feb 2020 2019 FY
Q3 2018 173,057,000 +16,104,000 +10% 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 172,415,000 +16,554,000 +11% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 162,379,000 +7,648,000 +4.9% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 159,524,000 +6,312,000 +4.1% 31 Dec 2017 10-K 01 Mar 2019 2018 FY
Q3 2017 156,953,000 +19,157,000 +14% 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 155,861,000 +19,259,000 +14% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 154,731,000 +18,580,000 +14% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 153,212,000 +17,923,000 +13% 31 Dec 2016 10-K 01 Mar 2018 2017 FY
Q3 2016 137,796,000 +4,579,000 +3.4% 30 Sep 2016 10-Q 04 Nov 2016 2016 Q3
Q2 2016 136,602,000 +4,417,000 +3.3% 30 Jun 2016 10-Q 04 Aug 2016 2016 Q2
Q1 2016 136,151,000 +4,700,000 +3.6% 31 Mar 2016 10-Q 04 May 2016 2016 Q1
Q4 2015 135,289,000 +4,073,000 +3.1% 31 Dec 2015 10-K 01 Mar 2017 2016 FY
Q3 2015 133,217,000 +4,969,000 +3.9% 30 Sep 2015 10-Q 06 Nov 2015 2015 Q3
Q2 2015 132,185,000 +4,899,000 +3.8% 30 Jun 2015 10-Q 06 Aug 2015 2015 Q2
Q1 2015 131,451,000 +4,515,000 +3.6% 31 Mar 2015 10-Q 01 May 2015 2015 Q1
Q4 2014 131,216,000 +14,722,000 +13% 31 Dec 2014 10-K 29 Feb 2016 2015 FY
Q3 2014 128,248,000 +12,258,000 +11% 30 Sep 2014 10-Q 07 Nov 2014 2014 Q3
Q2 2014 127,286,000 +11,603,000 +10% 30 Jun 2014 10-Q 01 Aug 2014 2014 Q2
Q1 2014 126,936,000 +11,475,000 +9.9% 31 Mar 2014 10-Q 08 May 2014 2014 Q1
Q4 2013 116,494,000 +1,235,000 +1.1% 31 Dec 2013 10-K 26 Feb 2015 2014 FY
Q3 2013 115,990,000 +917,000 +0.8% 30 Sep 2013 10-Q 07 Nov 2013 2013 Q3
Q2 2013 115,683,000 +903,000 +0.79% 30 Jun 2013 10-Q 09 Aug 2013 2013 Q2
Q1 2013 115,461,000 +870,000 +0.76% 31 Mar 2013 10-Q 09 May 2013 2013 Q1
Q4 2012 115,259,000 +774,000 +0.68% 31 Dec 2012 10-K 27 Feb 2014 2013 FY
Q3 2012 115,073,000 +647,000 +0.56% 30 Sep 2012 10-Q 09 Nov 2012 2012 Q3
Q2 2012 114,780,000 +475,000 +0.42% 30 Jun 2012 10-Q 09 Aug 2012 2012 Q2
Q1 2012 114,591,000 +568,000 +0.5% 31 Mar 2012 10-Q 04 May 2012 2012 Q1
Q4 2011 114,485,000 +19,968,000 +21% 31 Dec 2011 10-K 01 Mar 2013 2012 FY
Q3 2011 114,426,000 30 Sep 2011 10-Q 04 Nov 2011 2011 Q3
Q2 2011 114,305,000 30 Jun 2011 10-Q 05 Aug 2011 2011 Q2
Q1 2011 114,023,000 31 Mar 2011 10-Q 29 Apr 2011 2011 Q1
Q4 2010 94,517,000 31 Dec 2010 10-K 29 Feb 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.